ALACT.PA实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 23:35):

Stats
今日成交量	1.66M
平均成交量	58 523.00
市值	5.29M
EPS	€0 ( 2023-10-26 )
下一个收益日期	( €0 ) 2024-05-10
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-0.200
ATR14	€0.0220 (6.47%)

Groupe Actiplay SA 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Groupe Actiplay SA 财务报表

Annual	2022
营收:	€0
毛利润:	€-86 000.00 (0.00 %)
EPS:	€-1.580

FY	2022
营收:	€0
毛利润:	€-86 000.00 (0.00 %)
EPS:	€-1.580

FY	2021
营收:	€0.00
毛利润:	€0.00 (0.00 %)
EPS:	€-0.120

FY	2020
营收:	€0.00
毛利润:	€0.00 (0.00 %)
EPS:	€-0.726

Financial Reports:

No articles found.

Groupe Actiplay SA

Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.